Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer

In current practice, prostate cancer staging alone is not sufficient to adequately assess the patient’s prognosis and plan the management strategies. Multiple clinicopathological parameters and risk tools for prostate cancer have been developed over the past decades to better characterize the diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Saoud, Ragheed, Heidar, Nassib Abou, Cimadamore, Alessia, Paner, Gladell P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564222/
https://www.ncbi.nlm.nih.gov/pubmed/32957584
http://dx.doi.org/10.3390/cells9092116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564222/
https://www.ncbi.nlm.nih.gov/pubmed/32957584
http://dx.doi.org/10.3390/cells9092116

Ejemplares similares